Skip to main content
Addgene
Open Menu

TRIPZ Human MBD3 shRNA #3 (clone ID V3THS 392210)
(Plasmid #52354)

Print

Full plasmid sequence is not available for this item.

Loading...

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 52354 Standard format: Plasmid sent in bacteria as agar stab 1 $94

Backbone

  • Vector backbone
    TRIPZ
  • Backbone manufacturer
    Thermo Scientific
  • Vector type
    Mammalian Expression, Lentiviral, RNAi
  • Selectable markers
    Puromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    Stbl3
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    Human MBD3 shRNA
  • gRNA/shRNA sequence
    MBD3
  • Species
    H. sapiens (human)

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Purchased from Thermo Scientific

Terms and Licenses

Trademarks:

  • Zeocin® is an InvivoGen trademark.

Depositor Comments

sequencing primer: GGAAAGAATCAAGGAGG

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    TRIPZ Human MBD3 shRNA #3 (clone ID V3THS 392210) was a gift from Jacob Hanna (Addgene plasmid # 52354)

  • For your References section:

    Deterministic direct reprogramming of somatic cells to pluripotency. Rais Y, Zviran A, Geula S, Gafni O, Chomsky E, Viukov S, Mansour AA, Caspi I, Krupalnik V, Zerbib M, Maza I, Mor N, Baran D, Weinberger L, Jaitin DA, Lara-Astiaso D, Blecher-Gonen R, Shipony Z, Mukamel Z, Hagai T, Gilad S, Amann-Zalcenstein D, Tanay A, Amit I, Novershtern N, Hanna JH. Nature. 2013 Oct 3;502(7469):65-70. doi: 10.1038/nature12587. Epub 2013 Sep 18. 10.1038/nature12587 PubMed 24048479
Related items: